SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-21-033296
Filing Date
2021-03-08
Accepted
2021-03-08 16:28:49
Documents
2
Period of Report
2021-03-04

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm218923d4_4.html 4  
1 OWNERSHIP DOCUMENT tm218923d4_4.xml 4 4174
2 EXHIBIT 24 tm218923d4_ex24.htm EX-24 8701
  Complete submission text file 0001104659-21-033296.txt   14582
Mailing Address C/O ACHILLION PHARMACEUTICALS, INC. 300 GEORGE STREET NEW HAVEN CT 06511
Business Address
VAN NOSTRAND ROBERT L (Reporting) CIK: 0001225198 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33958 | Film No.: 21722322

Mailing Address 7 TIMES SQUARE SUITE 2503 NEW YORK NY 10036
Business Address 7 TIMES SQUARE SUITE 2503 NEW YORK NY 10036 6462005278
SELLAS Life Sciences Group, Inc. (Issuer) CIK: 0001390478 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations